Skip to main content
Top
Gepubliceerd in: Bijblijven 5/2018

30-04-2018

Overmatig zoutgebruik – meer dan bloeddruk alleen

Auteurs: Drs. Karin Boslooper, Prof. dr. Gerjan J. Navis

Gepubliceerd in: Bijblijven | Uitgave 5/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

In Nederland eet ruim 85 % van de bevolking te veel zout. Dit verhoogt het risico op hart- en vaatziekten en nieraandoeningen, vooral bij overgewicht. Recent onderzoek laat zien dat zout ook subcutaan kan worden opgeslagen, met mogelijk een rol in het ontstaan van hypertensie. Zoutbeperking is essentieel voor behandeling van hypertensie en chronische nierschade; de werking van RAAS-remmers verdwijnt bij hoog zoutgebruik. Het risico op te lage zoutinname is verwaarloosbaar en reflecteert mogelijk een slechte voedingsstatus. Feedback van de zoutinname kan de begeleiding verbeteren, evenals het betrekken van de naaste omgeving. Zoutbeperking hoort in een algeheel gezond voedingspatroon en betrokkenheid van een diëtist is aan te bevelen.
Literatuur
1.
go back to reference Kotchen TA, Cowley AW, Frohlich ED. Salt in health and disease – A delicate balance. N Engl J Med. 2013;368(13):1229–37.CrossRefPubMed Kotchen TA, Cowley AW, Frohlich ED. Salt in health and disease – A delicate balance. N Engl J Med. 2013;368(13):1229–37.CrossRefPubMed
2.
go back to reference Bertino M, Beauchamp GK, Engelman K. Long-term reduction in dietary sodium alters the taste of salt. Am J Clin Nutr. 1982;36(6):1134–44.CrossRefPubMed Bertino M, Beauchamp GK, Engelman K. Long-term reduction in dietary sodium alters the taste of salt. Am J Clin Nutr. 1982;36(6):1134–44.CrossRefPubMed
3.
5.
go back to reference Koning JB de. Zoutconsumptie van kinderen en volwassenen in Nederland. Bilthoven: RIVM; 2012. Koning JB de. Zoutconsumptie van kinderen en volwassenen in Nederland. Bilthoven: RIVM; 2012.
6.
go back to reference Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371(7):624–34.CrossRefPubMed Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371(7):624–34.CrossRefPubMed
7.
go back to reference Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.CrossRefPubMed Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.CrossRefPubMed
8.
go back to reference Gezondheidsraad. Richtlijnen goede voeding 2015. Den Haag; 2015 (publicatienr. 2015/24. ISBN 978-94-6281-089-1). Gezondheidsraad. Richtlijnen goede voeding 2015. Den Haag; 2015 (publicatienr. 2015/24. ISBN 978-94-6281-089-1).
9.
go back to reference Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials Of Hypertension Prevention (TOHP). BMJ. 2007;334(7599):885–8.CrossRefPubMedPubMedCentral Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials Of Hypertension Prevention (TOHP). BMJ. 2007;334(7599):885–8.CrossRefPubMedPubMedCentral
10.
go back to reference NHG-Standaard Cardiovasculair risicomanagement. M84 (eerste herziening). Huisarts Wet. 2012;55(1):14–28. NHG-Standaard Cardiovasculair risicomanagement. M84 (eerste herziening). Huisarts Wet. 2012;55(1):14–28.
11.
go back to reference He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346(3):f1325.CrossRefPubMed He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346(3):f1325.CrossRefPubMed
12.
go back to reference Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54(3):475–81.CrossRefPubMedPubMedCentral Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54(3):475–81.CrossRefPubMedPubMedCentral
13.
go back to reference Jager RL de, Maarseveen EM van, Bots ML, Blankestijn PJ. Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. Br J Clin Pharmacol. 2018;84(1):18–24.CrossRefPubMed Jager RL de, Maarseveen EM van, Bots ML, Blankestijn PJ. Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. Br J Clin Pharmacol. 2018;84(1):18–24.CrossRefPubMed
14.
go back to reference Heerspink HJL, Holtkamp FA, Parving H‑H, Navis GJ, Lewis JB, Ritz E, et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 2012;82(3):330–7.CrossRef Heerspink HJL, Holtkamp FA, Parving H‑H, Navis GJ, Lewis JB, Ritz E, et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 2012;82(3):330–7.CrossRef
15.
go back to reference Kwakernaak AJ, Krikken JA, Binnenmars SH, Visser FW, Hemmelder MH, Woittiez AJ, et al. Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(5):385–95.CrossRefPubMed Kwakernaak AJ, Krikken JA, Binnenmars SH, Visser FW, Hemmelder MH, Woittiez AJ, et al. Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(5):385–95.CrossRefPubMed
16.
go back to reference Meuleman Y, Brinke L ten, Kwakernaak AJ, Vogt L, Rotmans JI, Bos WJW, et al. Perceived barriers and support strategies for reducing sodium intake in patients with chronic kidney disease: a Qualitative Study. Int J Behav Med. 2015;22(4):530–9.CrossRefPubMed Meuleman Y, Brinke L ten, Kwakernaak AJ, Vogt L, Rotmans JI, Bos WJW, et al. Perceived barriers and support strategies for reducing sodium intake in patients with chronic kidney disease: a Qualitative Study. Int J Behav Med. 2015;22(4):530–9.CrossRefPubMed
17.
go back to reference Humalda JK, Klaassen G, Vries H de, Meuleman Y, Laverman GD, Bos WJW, et al. The ‘sublime’ approach: cost-efficacy of a novel self-management approach for dietary sodium restriction in ckd patients. Nephrology Dialysis Transplantation 2016;31(Suppl. 1):206–7. https://doi.org/10.1093/ndt/gfw167.24.CrossRef Humalda JK, Klaassen G, Vries H de, Meuleman Y, Laverman GD, Bos WJW, et al. The ‘sublime’ approach: cost-efficacy of a novel self-management approach for dietary sodium restriction in ckd patients. Nephrology Dialysis Transplantation 2016;31(Suppl. 1):206–7. https://​doi.​org/​10.​1093/​ndt/​gfw167.​24.CrossRef
19.
go back to reference Gant CM, Binnenmars SH, Berg E van den, Bakker SJL, Navis G, Laverman GD. Integrated assessment of pharmacological and nutritional cardiovascular risk management: Blood pressure control in the DIAbetes and LifEstyle Cohort Twente (DIALECT). Nutrients. 2017;9(7):E709.CrossRefPubMed Gant CM, Binnenmars SH, Berg E van den, Bakker SJL, Navis G, Laverman GD. Integrated assessment of pharmacological and nutritional cardiovascular risk management: Blood pressure control in the DIAbetes and LifEstyle Cohort Twente (DIALECT). Nutrients. 2017;9(7):E709.CrossRefPubMed
20.
go back to reference Mente A, O’Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016;388(10043):465–75.CrossRefPubMed Mente A, O’Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016;388(10043):465–75.CrossRefPubMed
Metagegevens
Titel
Overmatig zoutgebruik – meer dan bloeddruk alleen
Auteurs
Drs. Karin Boslooper
Prof. dr. Gerjan J. Navis
Publicatiedatum
30-04-2018
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Bijblijven / Uitgave 5/2018
Print ISSN: 0168-9428
Elektronisch ISSN: 1876-4916
DOI
https://doi.org/10.1007/s12414-018-0314-6

Andere artikelen Uitgave 5/2018

Bijblijven 5/2018 Naar de uitgave